Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3025% above fair value
$19.89−0.21 (-1.04%)
Close on Nov 13, 2026Market cap $1.01BP/E –Yield –
Cryoport gross margin
Gross margin is gross profit as a percentage of revenue.
Cryoport's gross margin for the twelve months ending Sep 30, 2026 was 46.9%. For fiscal 2025 it was 47.1%, against 44.4% the year before. The highest annual figure on record is 52.2% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.1% | +2.7 |
| FY2024 | Dec 31, 2024 | 44.4% | −0.2 |
| FY2023 | Dec 31, 2023 | 44.7% | +0.9 |
| FY2022 | Dec 31, 2022 | 43.8% | +0.4 |
| FY2021 | Dec 31, 2021 | 43.4% | −2.8 |
| FY2020 | Dec 31, 2020 | 46.2% | −5.0 |
| FY2019 | Dec 31, 2019 | 51.1% | −1.1 |
| FY2018 | Dec 31, 2018 | 52.2% | +20.0 |
| FY2016 | Mar 31, 2016 | 32.1% | +2.4 |
| FY2015 | Mar 31, 2015 | 29.7% | +13.3 |
| FY2014 | Mar 31, 2014 | 16.4% | +60.7 |
| FY2013 | Mar 31, 2013 | -44.3% | +106.3 |
| FY2012 | Mar 31, 2012 | -150.6% | +23.4 |
| FY2011 | Mar 31, 2011 | -174.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | 47.5% | −0.8 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 46.6% | −0.4 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 45.8% | +0.4 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 47.8% | +0.7 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 48.2% | +2.7 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 47.0% | +2.6 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 45.4% | +5.0 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 47.0% | +48.3 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 45.5% | +2.3 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 44.5% | +1.1 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 40.4% | −2.7 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -1.3% | −44.8 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 43.2% | −0.5 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 43.4% | −1.6 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 43.1% | +0.4 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 43.5% | +2.6 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 43.7% | +2.2 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 45.0% | −0.3 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 42.7% | −3.4 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | 41.0% | −0.2 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 41.5% | −12.7 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 45.2% | −9.4 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 46.1% | −7.7 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 41.1% | −12.2 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | 54.2% | +5.9 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | 54.6% | +3.4 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 53.8% | +1.9 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | 53.4% | +3.9 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | 48.3% | −3.5 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | 51.3% | −2.9 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | 51.9% | −2.4 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | 49.5% | +23.2 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | 51.8% | +21.4 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | 54.1% | +20.0 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | 54.3% | +16.9 |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | 26.3% | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | 30.3% | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | 34.1% | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | 37.4% | – |
See a number that looks wrong?